Company news

DRI Healthcare Trust news in 2022

DRI Healthcare Trust's news releases, calls and decks from 2022, newest first.

View company

DRI Healthcare Trust Declares Unit Distribution and Provides Update on Normal Course Issuer Bid

December 21, 2022

DRI Healthcare Trust Announces Acquisition of a Royalty Interest in the Worldwide Sales of Xenpozyme® (olipudase alfa) for the Treatment of Acid Sphingomyelinase Deficiency

November 28, 2022

DRI Healthcare Trust Reports Third Quarter 2022 Results

November 7, 2022

DRI Healthcare Trust Announces Appointment of Poonam Puri to Board of Trustees

November 7, 2022

DRI Healthcare Trust to Host Third Quarter Earnings Call and Webcast on November 8, 2022

October 25, 2022

DRI Healthcare Trust Announces Acquisition of a Royalty Interest in the Worldwide Sales of Omidria® for Intracameral Use During Cataract Surgery or Intraocular Lens Replacement

October 3, 2022

DRI Healthcare Trust Provides Update on Natpara Royalty

October 3, 2022

DRI Healthcare Trust Announces Acquisition of a Royalty Interest in Zejula®, Currently Approved for the Treatment of Ovarian Cancer with Additional Indications Under Development

September 12, 2022

DRI Healthcare Trust to Host Second Quarter Earnings Call and Webcast on August 4, 2022

July 21, 2022

DRI Healthcare Trust Announces Acquisition of a Royalty Interest in the Worldwide Sales of pegcetacoplan Including Empaveli® /Aspaveli® for the Treatment of Paroxysmal Nocturnal Hemoglobinuria

July 21, 2022

DRI Healthcare Trust Reports First Quarter 2022 Results

May 10, 2022

DRI Healthcare Trust to Host First Quarter Earnings Call and Webcast on May 11, 2022

April 27, 2022

DRI Healthcare Trust Announces Upsized Credit Facility

April 20, 2022

DRI Healthcare Trust Reports Fourth Quarter and Fiscal 2021 Results

March 7, 2022

DRI Healthcare Trust Comments on FDA Approval of VONJOTM (pacritinib)

March 1, 2022

DRI Healthcare Trust to Host Fourth Quarter Earnings Call and Webcast on March 8, 2022

February 22, 2022

Decks in 2022